通过天眼查大数据分析，浙江黎明智造股份有限公司共对外投资了10家企业，参与招投标项目18次，知 识产权方面有商标信息1条，专利信息122条，此外企业还拥有行政许可70个。 来源：金融界 浙江黎明最新一期业绩显示，截至2025一季报，公司营业总收入1.68亿元、同比增长5.96%，归属净利 润1341.29万元，同比减少23.42%，扣非净利润1232.61万元，同比减少23.15%，流动比率2.412、速动比 率1.701、资产负债率18.89%。 天眼查商业履历信息显示，浙江黎明智造股份有限公司，成立于1997年，位于舟山市，是一家以从事专 用设备制造业为主的企业。企业注册资本14688万人民币，实缴资本14688万人民币。公司法定代表人为 俞黎明。 金融界消息 截至2025年7月29日收盘，浙江黎明（603048）报收于19.16元，下跌1.19%，换手率 2.51%，成交量3.68万手，成交金额7029.57万元。 资金流向方面，今日主力资金净流出1615.55万元，占比成交额22.98%。其中，超大单净流出491.14万 元、占成交额6.99%，大单净流出1124.42万元、占成交额16.0%，中单净 ...

浙江京衡律师事务所 关于 法律意见书 地址：杭州市杭大路黄龙世纪广场C区十一层 邮编：310007 电话/Tel: (0571)8790 1648 传真/Fax:(0571) 8790 1646 网址/Website: www.celg.cn 二〇二五年七月 2024年度差异化分红事项之 浙江黎明智造股份有限公司 浙江京衡律师事务所 关于浙江黎明智造股份有限公司 2024年度差异化分红事项之 法律意见书 致:浙江黎明智造股份有限公司 浙江京衡律师事务所（以下简称"本所"或"京衡"）接受浙江黎明智造股份有 限公司(以下简称"浙江黎明"公司"或"上市公司")的委托,根据《中华人民共 和国公司法》（以下简称"《公司法》"）、《中华人民共和国证券法》（以下简 称"《证券法》"）、《上市公司股份回购规则》（以下简称"《回购规则》"）、 《上海证券交易所上市公司自律监管指引第7号 -- 回购股份（2025年3月修订）》 (以下简称"《监管指引第7号》")等相关法律、法规、规章和其他规范性文件及 《浙江黎明智造股份有限公司章程》(以下简称"《公司章程》")的规定,就公 司2024年度利润分配所涉及的差异化分红(以下简称"本 ...

证券代码：603048 证券简称：浙江黎明 公告编号：2025--024 浙江黎明智造股份有限公司 2024年年度权益分派实施公告 每股分配比例 A 股每股现金红利0.28元 相关日期 | 股份类别 | 股权登记日 | 最后交易日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | --- | --- | | Ａ股 | 2025/7/30 | － | 2025/7/31 | 2025/7/31 | 差异化分红送转： 是 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并 对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、 通过分配方案的股东大会届次和日期 本次利润分配方案经公司2025 年 5 月 29 日的2024年年度股东大会审议通过。 二、 分配方案 3. 差异化分红送转方案： （1）本次差异化分红送转方案 利 0.28 元（含税）。 （2）本次差异化分红除权（息）参考价格 根据上海证券交易所的相关规定，公司按照以下公式计算除权（息）开盘参考价： 除权（息）参考价格=（前收盘价格-现金红利）÷（1+流通股份变动比例） 根据公 ...

New Stock Issuance - New stock issued by Dingjia Precision at a price of 11.16 on July 22, 2025[1] - ST Kelly's tender offer period is from July 17 to August 15, 2025[1] - ST Zitian and other companies have also announced new stock issuances[1] Market Alerts - Significant abnormal fluctuations reported for several stocks including Guangshengtang and Huayin Power[1] - Multiple companies have disclosed announcements regarding stock performance and market activities[1] - The report includes links to detailed announcements for various stocks, indicating ongoing market monitoring[1]

New Stock Issuance - The new stock issued by Hanguo Group is priced at 15.43 RMB per share[1] - The subscription period for the tender offer of ST Kelly is from July 17, 2025, to August 15, 2025[1] Abnormal Fluctuations - Several stocks, including ST Zitian and Guangshengtang, have reported severe abnormal fluctuations[2] - The announcement links for stocks experiencing abnormal fluctuations are provided for investor reference[2] Market Updates - A total of 30 stocks have been listed for trading updates, with various announcements made between July 15 and July 21, 2025[1] - The report includes links to detailed announcements for each stock, ensuring transparency and accessibility for investors[1]

证券代码：603048 证券简称：浙江黎明 公告编号：2025-023 浙江黎明智造股份有限公司 股票交易异常波动公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 浙江黎明智造股份有限公司（以下简称"公司"或"本公司"）股票于 2025 年 7 月 15 日、7 月 16 日、7 月 17 日连续三个交易日内日收盘价格涨幅偏离 值累计超过 20%。根据《上海证券交易所交易规则》的有关规定，属于股票交易异 常波动情形。 经公司自查并向控股股东、实际控制人核实，截至本公告披露日，不存在 应披露而未披露的重大事项。 公司敬请广大投资者注意二级市场交易风险，理性决策，审慎投资。 一、股票交易异常波动的具体情况 公司股票于2025年7月15日、7月16日、7月17日连续三个交易日内日收盘价格 涨幅偏离值累计超过20%。根据《上海证券交易所交易规则》的有关规定，属于股 票交易异常波动情形。 二、公司关注并核实的相关情况 针对公司股票交易异常波动的情况，公司对有关事项进行了核查，并发函问询 了控股股东及实际控制人， ...

Group 1: Stock Performance - Zhejiang Zhenyuan and Asia-Pacific Pharmaceutical both achieved a 2-day limit-up with increases of 10.01% and 9.98% respectively, driven by innovation in pharmaceuticals [2] - Chengdu XianDao saw a first board listing with a significant rise of 20.02%, attributed to innovative drug developments [2] - TaiJing Technology and YanHua Intelligent both recorded first board listings with increases of 9.97% and 9.94%, linked to Huawei's influence in robotics [5] Group 2: AI and Robotics - Nvidia's CEO suggested that Huawei's AI chips could potentially replace Nvidia's offerings, indicating a competitive shift in the AI chip market [4] - The domestic robotics industry is gaining traction with significant orders being awarded, highlighting its importance in national competition [7] Group 3: Market Trends - The light communication sector is expected to see sustained growth due to high demand in both domestic and international markets, with performance likely to continue improving [13] - The low-altitude economy is gaining attention, with a notable $1 billion procurement agreement signed for eVTOL aircraft, indicating growth potential in this sector [17] Group 4: Consumer and Retail - The Chinese government is implementing measures to boost consumer spending, which is expected to positively impact the retail sector [21] - Companies like Guoguang Chain and Hanshang Group have seen first board listings with increases of 9.98% and 9.97%, reflecting the positive sentiment in the retail market [23] Group 5: Solar and Food & Beverage - The price of polysilicon has increased by 12.4% week-on-week, indicating a rising trend in the solar industry [24] - The food and beverage sector is also benefiting from government initiatives aimed at enhancing consumer demand, with companies like Huangshi Group seeing a 10.10% increase [26]

Market Overview - The Shanghai Composite Index closed at 3500.62 points, below the five-day moving average, with a change of -0.12% [1] - The total trading volume of A-shares reached 926.995 billion yuan [1] Stock Performance - A total of 881 A-shares have prices that surpassed the five-day moving average [1] - Stocks with significant deviation rates include: - Yangdian Technology (13.80%) - Jujie Microfiber (13.15%) - Jindao Technology (9.04%) [1][2] - Stocks with minor deviation rates that just crossed the five-day moving average include: - Shanghai Laishi - Langsha Shares - Shanhe Intelligent [1] Individual Stock Data - Yangdian Technology (301012) had a trading rate of 20.02% with a latest price of 23.14 yuan and a deviation rate of 13.80% [2] - Jujie Microfiber (300819) also had a trading rate of 20.02%, latest price of 28.18 yuan, and a deviation rate of 13.15% [2] - Jindao Technology (301279) reported a trading rate of 13.38%, latest price of 25.00 yuan, and a deviation rate of 9.04% [2]

Group 1 - CITIC Construction Investment has received approval from the China Securities Regulatory Commission to issue perpetual subordinated bonds with a total face value of no more than 20 billion yuan [1] - Bluefocus Technology has received a loan commitment of up to 900 million yuan from CITIC Bank for stock repurchase [1] - Huaren Pharmaceutical's subsidiary has received approval for the listing of Bumetanide raw materials, which are used to treat severe heart failure and hypertension emergencies [3] Group 2 - Betta Pharmaceuticals has received approval for the listing of Enasidenib capsules in Macau, aimed at treating ALK-positive locally advanced or metastatic non-small cell lung cancer [4] - Juewei Food plans to use 110 million yuan of idle fundraising for cash management, with an expected annual yield of 1.00%-1.89% [6] - China Huadian has successfully completed the issuance of 1 billion yuan medium-term notes with a coupon rate of 1.95% [9] Group 3 - Fosun Pharma's subsidiary has received a GMP certificate from the Belgian Federal Agency for Medicines and Health Products for the production facilities of two monoclonal antibodies [11] - China Nuclear Engineering has signed a civil engineering contract for the Taishan Nuclear Power Units 3 and 4 [13] - Kanglongda has faced administrative regulatory measures from the Zhejiang Securities Regulatory Bureau due to the failure of performance commitment parties to fulfill compensation obligations [15] Group 4 - Gaoling Information has received three invention patent certificates in the second quarter, covering various technological fields [16] - Weimais plans to use 190 million yuan of excess fundraising to increase capital in its subsidiary for building a new energy vehicle powertrain production base [17] - Huazhong Technology has received a project designation notice from a leading eVTOL manufacturer for the development and supply of an intelligent cockpit multimedia display system [19] Group 5 - Madi Technology expects a net profit of 25 million to 27 million yuan for the first half of 2025, marking a turnaround from a loss in the previous year [19] - Dazhong Mining's subsidiary has obtained a mining license for the Zhouyoufang Iron Mine, increasing production capacity to 6.5 million tons per year [20] - Zhongguancun's subsidiary has had its application for the listing of Arolol hydrochloride tablets accepted by the National Medical Products Administration [21] Group 6 - Tianhong Co. has signed a property management contract worth 15 million yuan with a local company [22] - Dong'an Power has secured nine new market designation agreements in the second quarter, with a projected total sales volume of 1.5 million units [24] - Zhujiang Co. has appointed Zhao Kun as the new deputy general manager [25] Group 7 - Jinyi Industrial has won a bid for a project worth 335 million yuan from the China Railway Shanghai Bureau Group [26] - Kangchen Pharmaceutical has received a clinical trial notification for its innovative drug KC1086, aimed at treating advanced solid tumors [27] - Changhua Group has received a project designation notice from a new energy vehicle company, with an expected total sales amount of 970 million yuan [29] Group 8 - Lingxiao Pump Industry plans to use 60 million yuan of idle funds to purchase financial products [31] - Mould Technology has received a project designation for exterior parts from a well-known North American electric vehicle company, with an expected total sales of 1.236 billion yuan [34] - Fulongma has pre-bid for five sanitation service projects in June, with a total contract amount of 181 million yuan [35] Group 9 - Changchun High-tech plans to issue H-shares and list on the Hong Kong Stock Exchange [36] - *ST Yuancheng is under investigation by the CSRC for suspected false financial disclosures [37] - Beilu Pharmaceutical's subsidiary has received approval for the listing of Iopamidol raw materials [38] Group 10 - Zhejiang Liming's shareholder plans to reduce their stake by up to 2.93% [39] - Zhejiang Liming's actual controller has committed not to reduce their holdings within a year [40] - SAIC Motor reported a total vehicle sales of 2.0526 million units in the first half of 2025, a year-on-year increase of 12.35% [41] Group 11 - Xinhongcheng expects a net profit increase of 50%-70% for the first half of 2025 [42] - Xianhe Co. plans to invest 11 billion yuan in a bamboo pulp paper integrated project [42] - Great Wall Motors reported a total vehicle sales of 569,800 units in the first half of 2025, a year-on-year increase of 1.81% [43] Group 12 - Dongfeng Co. received a government subsidy of 10 million yuan [44] - Zhongke Environmental Protection has acquired two water environmental companies in Guangxi for a total of 353 million yuan [45] - Anji Food's H-share public offering is priced at 60 Hong Kong dollars per share [46]

Core Viewpoint - Zhejiang Liming announced a share reduction plan by a major shareholder, leading to a significant drop in the company's stock price, closing at 18.32 yuan, down 10.02% [1]. Shareholder Reduction Plan - Shareholder Zhoushan Yifan Equity Investment Partnership plans to reduce up to 4,300,000 shares, representing no more than 2.93% of the total share capital, due to funding needs [1]. - The reduction will occur through centralized bidding or block trading, with a maximum of 1,460,000 shares via centralized bidding and 2,930,000 shares via block trading, scheduled from July 25, 2025, to October 24, 2025 [1]. Current Shareholding Structure - As of the announcement date, Yifan Investment holds 9,160,000 shares, accounting for 6.24% of the total share capital, and is the third-largest shareholder [1]. - The actual controllers, Yu Liming and Zheng Xiaomin, have committed not to reduce their holdings through controlled companies for 12 months following the announcement [1][2]. Control and Ownership - The reduction plan will not lead to a change in control of the company, as the actual controllers and their related entities hold a combined 70.87% of the shares [3]. - Zhejiang Free Trade Zone Liming Investment Co., Ltd. and Zhejiang Free Trade Zone Jiheng Investment Co., Ltd. are controlled by Yu Liming and Zheng Xiaomin, holding 42.55% and 25.53% of shares, respectively [3]. Company Background - Zhejiang Liming was listed on the Shanghai Stock Exchange on November 16, 2021, with an issuance of 36.72 million shares at a price of 17.37 yuan per share, raising a total of 638 million yuan [3]. - The funds raised are allocated for various projects, including the construction of a precision stamping parts production line and the development of engine brake systems [4].